Lu AF28996 in Patients With Parkinson's Disease (PD)

STATUS

Recruiting
participants needed

10
sponsor

H. Lundbeck A/S

Send

Updated on 19 February 2024

See if I qualify

parkinson's disease

mini-mental state examination

levodopa

benserazide

carbidopa

mental state examination

Summary

The purpose of this study is to investigate the safety of Lu AF28996, how well it is tolerated and what the body does to the drug in Patients With Parkinson's Disease

Details

Condition	Parkinson's Disease, Parkinson's Disease
Age	45-75 years
Treatment	Lu AF28996
Clinical Study Identifier	NCT04291859
Sponsor	H. Lundbeck A/S
Last Modified on	19 February 2024

How understandable was the trial content above?

Hard to understand

Easy to understand

Eligibility		Yes	No	Not Sure
Inclusion Criteria
	Men or women diagnosed with idiopathic PD (consistent with the UK PD Society Brain Bank Criteria for the Diagnosis of PD), Modified Hoehn and Yahr Staging 4 in 'OFF' and 3 in 'ON' state and a Mini Mental State Examination Score >26\
	Patients must currently have a good response to levodopa, and be receiving a stable dose of levodopa (>3 doses per day of standard levodopa or >3 doses per day of carbidopa and levodopa, or benserazide and levodopa, Extended-Release Capsules) for at least 4 weeks prior to screening. If the patient's response to Levodopa has not been previously documented in medical records, the patient will be submitted to a Levodopa challenge test while in practically defined OFF state prior to enrolment
	Patients must experience recognizable and predictable motor fluctuations (with at least 1.5 hours of OFF-periods in the awake time, including predictable morning OFF episodes) causing clinically significant disability during the 4-week screening period. This will be documented during a defined period of 3 consecutive days prior to enrolment, using a patient diary
Exclusion Criteria
	The patient has or has had one or more of the following conditions that are considered clinically relevant in the context of the study; other neurological disorder, psychiatric disorder, seizure disorder or encephalopathy, respiratory disease, hepatic impairment or renal insufficiency, metabolic disorder, endocrinological disorder, haematological disorder, infectious disorder, any clinically significant immunological condition, elevated intra-ocular pressure or is at risk of acute narrow-angle glaucoma
	Other in- and exclusion criteria may apply

How to participate?

Step 1 Connect with a study center

Select a site
Send a message

You have contacted , on

Your message has been sent to the study team at ,

A copy of the message has been sent to your email

What happens next?

You can expect the study team to contact you via email or phone in the next few days.
Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Primary Contact

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).

Step 2 Get screened

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

Step 3 Enroll in the clinical study

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Step 4 Get your study results

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Browse trials for

parkinson's disease

mini-mental state examination

levodopa

benserazide

carbidopa

mental state examination

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Study Definition

Wikipedia

Lu AF28996 in Patients With Parkinson's Disease (PD)